Trial Profile
A Single-Blind Study to Evaluate the Irritation Potential of Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects and Acne Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 1940029 (Primary) ; Sodium lauril-sulfate
- Indications Acne
- Focus Adverse reactions
- Sponsors GSK
- 11 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2015 Planned End Date changed from 1 Oct 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 24 Mar 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.